Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dalpiciclib Isethionate Tablets

Approval Number

国药准字H20210055

Company江苏恒瑞医药股份有限公司

Registration Date

December 31, 2021

Drug Information

Generic Name

羟乙磺酸达尔西利片

Trade Name

艾瑞康

Dosage Form

片剂

Strength

125mg（按C25H30N6O2计）

Drug Type

化学药品

Registration Date

December 31, 2021

Company Information

Applicant Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区黄河路38号

Manufacturing Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区临港产业区东晋路

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

羟乙磺酸达尔西利片 - NMPA 批准文号 | MedPath